Sunpointe’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229K Sell
457
-61
-12% -$29.3K 0.07% 254
2026
Q1
$255K Buy
518
+43
+9% +$23.3K 0.08% 218
2025
Q4
$275K Buy
+475
New +$269K 0.09% 197
2025
Q1
Sell
-627
Closed -$326K 199
2024
Q4
$326K Sell
627
-4
-0.6% -$2.2K 0.16% 120
2024
Q3
$391K Buy
631
+10
+2% +$5.92K 0.32% 81
2024
Q2
$344K Buy
621
+50
+9% +$28.6K 0.22% 94
2024
Q1
$332K Buy
571
+30
+6% +$16.8K 0.37% 85
2023
Q4
$287K Buy
+541
New +$262K 0.36% 89

Other funds holding TMO

Sunpointe's TMO Position: Q2 2026 in Review

Sunpointe reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, selling an estimated $29.3K and leaving 457 shares worth $229K. The position accounts for 0.07% of the portfolio, ranked #254.

Sunpointe first reported a position in TMO in Q4 2023 and has held it in 8 quarters since. The position peaked at $391K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Sunpointe held 457 shares of Thermo Fisher Scientific worth $229K as of Q2 2026.
  • Sunpointe sold 61 Thermo Fisher Scientific shares in Q2 2026, an estimated $29.3K.
  • Thermo Fisher Scientific made up 0.07% of Sunpointe's portfolio in Q2 2026, its #254 holding.
  • Sunpointe first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 8 quarters since.
  • Sunpointe's Thermo Fisher Scientific position peaked at $391K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sunpointe's 13F filing for Q2 2026, filed 24 Jul 2026.